Related Experiment Video
Updated: Jul 6, 2026
06:05
Modified Radical Neck Dissection for Cervical Metastasis
Published on: February 20, 2026
High-dose-rate brachytherapy plus neck dissection for nodal disease
Jonathan J Beitler1, Madhur Garg, Randall P Owen
1Department of Radiation Oncology, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, New York 10471, USA. jbeitler92@alumni.gsb.columbia.edu
Head & Neck
|March 11, 2008
Summary
High-dose-rate brachytherapy significantly improved regional control for advanced nodal disease, achieving 82% success in initial treatments. This advanced radiation technique offers excellent outcomes for challenging head and neck cancers.
Area of Science:
- Oncology
- Radiation Oncology
- Head and Neck Cancer
Background:
- Conventional treatments like chemoradiation offer limited regional control for advanced nodal disease.
- External beam radiation therapy has shown marginal improvements.
Purpose of the Study:
- To evaluate the efficacy of high-dose-rate brachytherapy in achieving regional control for advanced nodal head and neck cancer.
- To assess brachytherapy outcomes in various clinical scenarios, including initial treatment, recurrence, and persistent disease.
Main Methods:
- A cohort of 24 patients with advanced nodal disease received brachytherapy (20 Gy in 10 fractions) combined with external radiation, neck dissection, and/or chemotherapy.
- Brachytherapy was used for initial bulky disease, recurrent disease, persistent disease, or inadequate external radiation.
Main Results:
- Overall 2-year actuarial regional control was 67%.
- Patients receiving brachytherapy as part of initial treatment achieved 82% regional control, even with large tumors (mean 8.7 cm).
- Regional control was 56% for patients with a disease-free interval of at least 3 years.
Conclusions:
- High-dose-rate brachytherapy is an effective method for achieving excellent regional control in advanced nodal head and neck cancer.
- Brachytherapy demonstrates significant benefit, particularly when used in the initial management of bulky disease.
